Gantenerumab for Early Alzheimer's Disease: An Updated Systematic Review and Meta‐Analysis

ABSTRACT Introduction Alzheimer's disease (AD) is a progressive neurodegenerative disorder with limited treatment options. Gantenerumab, a β‐amyloid–targeting monoclonal antibody, has shown mixed clinical results. With new trial data available, this updated systematic review and meta‐analysis re‐eva...

Descrición completa

Detalles Bibliográficos

Principais autores:	Muhammad Nouman Javed, Saim Mahmood Khan, Smaher Mustafa, Amna Mujtaba, Hassaan Amin, Naveen Azhar, Abdullah Hameed, Alaa Zayed, Maliha Khalid, Jawairya Muhammad Hussain
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2026-08-01
Series:	Brain and Behavior
Assuntos:	early Alzheimer's disease gantenerumab monoclonal antibody amyloid
Acceso en liña:	https://doi.org/10.1002/brb3.71643
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!